ArticleAllergy2022

Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern.

Dominik A Rothen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.